Cargando…

Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial

BACKGROUND: Previous studies have suggested that any benefits of folic acid-based therapy to lower serum homocysteine in prevention of cardiovascular events might be offset by concomitant use of antiplatelet therapy. We aimed to establish whether there is an interaction between antiplatelet therapy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hankey, Graeme J, Eikelboom, John W, Yi, Qilong, Lees, Kennedy R, Chen, Christopher, Xavier, Denis, Navarro, Jose C, Ranawaka, Udaya K, Uddin, Wasim, Ricci, Stefano, Gommans, John, Schmidt, Reinhold
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lancet Pub. Group 2012
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3361667/ https://www.ncbi.nlm.nih.gov/pubmed/22554931 http://dx.doi.org/10.1016/S1474-4422(12)70091-1

Ejemplares similares

The effect of homocysteine-lowering with B-vitamins on osteoporotic fractures in patients with cerebrovascular disease: substudy of VITATOPS, a randomised placebo-controlled trial
por: Gommans, John, et al.
Publicado: (2013)

Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack
por: Wang, Yongjun, et al.
Publicado: (2019)

Refining prediction of major bleeding on antiplatelet treatment after transient ischaemic attack or ischaemic stroke
por: Hilkens, Nina A, et al.
Publicado: (2020)

Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis
por: Niu, Peng-Peng, et al.
Publicado: (2016)

Does prior use of antiplatelet therapy modify the effect of dual antiplatelet therapy in transient ischaemic attack/minor ischaemic stroke: A systematic review and meta‐analysis
por: Clarke, Aoibhin, et al.
Publicado: (2022)

Dual versus mono antiplatelet therapy for acute non-cardioembolic ischaemic stroke or transient ischaemic attack: a systematic review and meta-analysis
por: Yang, Yingying, et al.
Publicado: (2018)

Personalised antiplatelet therapy based on pharmacogenomics in acute ischaemic minor stroke and transient ischaemic attack: study protocol for a randomised controlled trial
por: Zhang, Xiao-Guang, et al.
Publicado: (2019)

Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial
por: Hoshino, Haruhiko, et al.
Publicado: (2021)

Precision antiplatelet therapy for the prevention of ischaemic stroke
por: Wang, David
Publicado: (2021)

Transient Cerebral Ischaemic Attacks
por: Laiwah, A.C. Yeung
Publicado: (1982)

Sodium Valproate, a Histone Deacetylase Inhibitor, Is Associated With Reduced Stroke Risk After Previous Ischemic Stroke or Transient Ischemic Attack
por: Brookes, Rebecca L., et al.
Publicado: (2018)

Transient ischaemic attacks: mimics and chameleons
por: Nadarajan, V, et al.
Publicado: (2014)

Efficacy and Safety of Alirocumab in Japanese Patients with Diabetes Mellitus: Post-hoc Subanalysis of ODYSSEY Japan
por: Teramoto, Tamio, et al.
Publicado: (2019)

Stopping “transient ischemic attacks” by antiplatelet withdrawal
por: Palaiodimou, Lina, et al.
Publicado: (2021)

Secondary prevention medication persistence and prognosis of acute ischaemic stroke or transient ischaemic attack
por: Zhang, Lei, et al.
Publicado: (2021)

Comparative effectiveness of combined antiplatelet treatments in acute minor ischaemic stroke
por: Kim, Shina, et al.
Publicado: (2021)

Management of peripheral arterial disease in the elderly: focus on cilostazol
por: Falconer, Travis M, et al.
Publicado: (2008)

Aortic Valve Fibroelastoma Masquerading as Transient Ischaemic Attack
por: Gowland, Penelope-Anne, et al.
Publicado: (2012)

Xanthine oxidase inhibition for the improvement of long-term outcomes following ischaemic stroke and transient ischaemic attack (XILO-FIST) – Protocol for a randomised double blind placebo-controlled clinical trial
por: Dawson, Jesse, et al.
Publicado: (2018)

Transient ischaemic attack and ischaemic stroke: constructing episodes of care using hospital claims data
por: Sluggett, Janet K, et al.
Publicado: (2013)

CO(2) combining power and outcomes in patients with acute ischaemic stroke or transient ischaemic attack
por: Wang, Anxin, et al.
Publicado: (2020)

Man-In-The-Middle Attacks in Vehicular Ad-Hoc Networks: Evaluating the Impact of Attackers’ Strategies
por: Ahmad, Farhan, et al.
Publicado: (2018)

Personalized antiplatelet therapy: state of the art
por: Gurbel, Paul A, et al.
Publicado: (2012)

Mitochondrial DNA haplogroups and risk of transient ischaemic attack and ischaemic stroke: a genetic association study
por: Chinnery, Patrick F, et al.
Publicado: (2010)

Safety and efficacy of intensive vs. guideline antiplatelet therapy in high‐risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388)
Publicado: (2015)

State of the art: Oral antiplatelet therapy
por: Gurbel, Paul A, et al.
Publicado: (2016)

Management of Transient Cerebral Ischaemic Attacks by Hospital Doctors in Scotland
por: Laiwah, A. C. Yeung
Publicado: (1983)

Low serum albumin levels predict poor outcome in patients with acute ischaemic stroke or transient ischaemic attack
por: Zhou, Hongyu, et al.
Publicado: (2021)

Association of clinical and aetiologic subtype of acute ischaemic stroke with inflammation, oxidative stress and vascular function: A cross-sectional observational study
por: Beer, Christopher, et al.
Publicado: (2011)

Systemic markers of inflammation are independently associated with S100B concentration: results of an observational study in subjects with acute ischaemic stroke
por: Beer, Christopher, et al.
Publicado: (2010)

Ticagrelor Monotherapy After 3-Month Dual Antiplatelet Therapy in Acute Coronary Syndrome by High Bleeding Risk: The Subanalysis From the TICO Trial
por: Lee, Yong-Joon, et al.
Publicado: (2021)

The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis
por: Potter, Kathleen, et al.
Publicado: (2008)

Transient ischaemic attack as presentation of late stage Loeffler’s eosinophilic myocarditis
por: Rodríguez-Pérez, Álvaro, et al.
Publicado: (2023)

Xanthine oxidase inhibition and white matter hyperintensity progression following ischaemic stroke and transient ischaemic attack (XILO-FIST): a multicentre, double-blinded, randomised, placebo-controlled trial
por: Dawson, Jesse, et al.
Publicado: (2023)

Lipid management in ischaemic stroke or transient ischaemic attack in China: result from China National Stroke Registry III
por: Xu, Yu-Yuan, et al.
Publicado: (2023)

Statistical analysis plan for the ‘Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke’ (TARDIS) trial
por: Bath, Philip M W, et al.
Publicado: (2015)

Prevalence and long-term clinical significance of intracranial atherosclerosis after ischaemic stroke or transient ischaemic attack: a cohort study
por: Ovesen, Christian, et al.
Publicado: (2013)

Current Antiplatelet Treatment Strategy in Patients with Diabetes Mellitus
por: Jung, Jung Hwa, et al.
Publicado: (2015)

Transient ischaemic attack: a qualitative study of the long term consequences for patients
por: Croot, Elizabeth J, et al.
Publicado: (2014)

Management of transient ischaemic attacks in the emergency department: a quality improvement project
por: Wydall, Simon, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ia9somjtv307ll694sk4f19tr4